NOVARTIS PHARMA AG's Net Worth

$1.44 Billion

Estimate Recalculated Feb 26, 2024 04:10PM EST

Who is NOVARTIS PHARMA AG?

NOVARTIS PHARMA AG has an estimated net worth of $1.44 Billion. This is based on reported shares across multiple companies, which include REGENERON PHARMACEUTICALS INC, Cellular Biomedicine Group, Inc., Poseida Therapeutics, Inc., ALNYLAM PHARMACEUTICALS, INC., IDENIX PHARMACEUTICALS INC, and PRECISION BIOSCIENCES INC.

SEC CIK

NOVARTIS PHARMA AG's CIK is 0001030617

Past Insider Trading and Trends

2012 was NOVARTIS PHARMA AG's most active year for acquiring shares with 19 total transactions. NOVARTIS PHARMA AG's most active month to acquire stocks was the month of January. 2005 was NOVARTIS PHARMA AG's most active year for disposing of shares, totalling 1 transactions. NOVARTIS PHARMA AG's most active month to dispose stocks was the month of June. 2005 saw NOVARTIS PHARMA AG paying a total of $105,141,026.65 for 5,126,224 shares, this is the most they've acquired in one year. In 2014 NOVARTIS PHARMA AG cashed out on 33,320,674 shares for a total of $816,356,513.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

REGENERON PHARMACEUTICALS INC (REGN) Snapshot price: $941

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-7.53M
$11.06
-$83,249,173.00
0
Nov 8
Form 3
0
0
No matching records found

Cellular Biomedicine Group, Inc. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
0
0
No matching records found

Poseida Therapeutics, Inc. (PSTX) Snapshot price: $3.405

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
5.91M
5.91M
Jul 14
Form 3
0
0
No matching records found

ALNYLAM PHARMACEUTICALS, INC. (ALNY) Snapshot price: $169.09

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-27.70%
-1.55M
$19.42
-$30,137,820.32
4.05M
Sep 20
Form 4
+1.00%
55.22K
$17.99
$993,461.77
5.6M
Apr 23
Form 4
+1.20%
65.92K
$17.50
$1,153,635.00
5.55M
May 6
Form 4
+4.06%
213.89K
$25.29
$5,409,227.52
5.48M
May 8
Form 3
0
0
No matching records found

IDENIX PHARMACEUTICALS INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-33.32M
$24.50
-$816,356,513.00
0
Aug 5
Form 4
+0.26%
84.89K
$3.43
$291,282.90
33.32M
Feb 23
Form 4/A
+0.04%
26.76K
$3.83
$114,522.56
66.43M
Nov 22
Form 4
+0.08%
50.53K
$3.80
$206,400.37
66.44M
Nov 22
Form 4
+5.69%
1.79M
$2.80
$4,999,999.20
33.19M
Apr 13
Form 4
+0.02%
20.99K
$3.41
$55,416.68
94.19M
Feb 25
Form 4
+0.02%
17.08K
$3.49
$46,689.69
94.13M
Nov 26
Form 4/A
+0.12%
37.21K
$2.45
$91,009.11
31.36M
Aug 13
Form 4
+0.04%
37.21K
$3.08
$91,009.11
94.08M
Aug 23
Form 4
+0.00%
1.35K
$2.41
$3,255.91
31.32M
Jun 8
Form 4
+0.01%
1.87K
$2.41
$4,511.52
31.32M
Feb 26
Form 4/A
+0.01%
3.57K
$2.41
$8,606.11
31.32M
Aug 21
Form 4
+0.01%
3.43K
$2.41
$8,268.71
31.32M
Aug 21
Form 4
+0.01%
2.45K
$2.62
$6,421.62
31.32M
May 29
Form 4
+0.02%
5.44K
$2.41
$13,120.04
31.31M
Feb 23
Form 4
+0.02%
4.75K
$4.05
$19,225.35
31.31M
Nov 19
Form 4
+0.01%
4.65K
$2.93
$13,636.22
31.3M
Sep 2
Form 4
+0.00%
924
$2.41
$2,226.84
31.3M
May 29
Form 4
+0.00%
365
$20.48
$7,475.20
31.3M
Jun 6
Form 4
+0.01%
2.94K
$16.23
$47,683.74
31.3M
Apr 4
Form 4
+14.40%
3.94M
$20.61
$81,185,489.91
31.3M
Oct 31
Form 4
+4.54%
1.19M
$20.18
$23,955,536.74
27.36M
Sep 2
Form 4
+13.48%
6.5M
$14.00
$75,600,000.00
54.71M
Jul 27
Form 3
0
0
No matching records found